Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction-Reference-Cited by-同舟云学术

Pharmacokinetic Profile of Controlled-Release Carvedilol in Patients with Left Ventricular Dysfunction Associated with Chronic Heart Failure or After Myocardial Infarction

Published:2006-10 Issue:7 Volume:98 Page:39-45
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Packer Milton,Lukas Mary Ann,Tenero David M.,Baidoo Charlotte A.,Greenberg Barry H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference11 articles.

1. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure;Packer;N Engl J Med,1996

2. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure: the PRECISE trial;Packer;Circulation,1996

3. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure;Colucci;Circulation,1996

4. Effect of carvedilol on survival in severe chronic heart failure;Packer;N Engl J Med,2001

5. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial;Lancet,2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of sustained-release CARvedilol in patients with hypErtension and heart failure with preserved ejection fraction: a study protocol for a pilot randomized controlled trial (CARE-preserved HF);Frontiers in Cardiovascular Medicine;2024-04-26

2. Influence of Desialylation on the Drug Binding Affinity of Human Alpha-1-Acid Glycoprotein Assessed by Microscale Thermophoresis;Pharmaceutics;2024-02-05

3. How carvedilol does not activate β2-adrenoceptors;Nature Communications;2023-11-30

4. Differential Effects of the Betablockers Carvedilol, Metoprolol and Bisoprolol on Cardiac Kv4.3 (Ito) Channel Isoforms;International Journal of Molecular Sciences;2023-09-08

5. Enhanced Efficacy of Carvedilol by Utilization of Solid Dispersion and Other Novel Strategies: A Review;Cardiovascular & Hematological Disorders-Drug Targets;2023-09